MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics
Authors:
- Marie Helene Schernthaner-ReiterMarie Helene Schernthaner-Reiter
- Giampaolo TrivellinGiampaolo Trivellin
- Constantine A. StratakisCSConstantine A. Stratakis
- 9 January 2015
- journal article
- review article
- Published by S. Karger AG in Neuroendocrinology
- Vol. 103 (1) , 18-31
Abstract
Pituitary adenomas are a common feature of a subset of endocrine neoplasia syndromes, which have otherwise highly variable disease manifestations. We provide here a review of the clinical features and human molecular genetics of multiple endocrine neoplasia (MEN) type 1 and 4 (MEN1 and MEN4, respectively) and Carney complex (CNC). MEN1, MEN4, and CNC are hereditary autosomal dominant syndromes that can present with pituitary adenomas. MEN1 is caused by inactivating mutations in the MEN1 gene, whose product menin is involved in multiple intracellular pathways contributing to transcriptional control and cell proliferation. MEN1 clinical features include primary hyperparathyroidism, pancreatic neuroendocrine tumours and prolactinomas as well as other pituitary adenomas. A subset of patients with pituitary adenomas and other MEN1 features have mutations in the CDKN1B gene; their disease has been called MEN4. Inactivating mutations in the type 1α regulatory subunit of protein kinase A (PKA; the PRKAR1A gene), that lead to dysregulation and activation of the PKA pathway, are the main genetic cause of CNC, which is clinically characterised by primary pigmented nodular adrenocortical disease, spotty skin pigmentation (lentigines), cardiac and other myxomas and acromegaly due to somatotropinomas or somatotrope hyperplasia.Keywords
This publication has 197 references indexed in Scilit:
- A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterizationHuman Mutation, 2010
- SDH-related pheochromocytoma and paragangliomaBest Practice & Research Clinical Endocrinology & Metabolism, 2010
- Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1–associated primary hyperparathyroidismJournal of Bone and Mineral Research, 2010
- Alternate protein kinase A activity identifies a unique population of stromal cells in adult boneProceedings of the National Academy of Sciences, 2010
- Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/− or Rb1+/− backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signalingHuman Molecular Genetics, 2010
- Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistanceBreast Cancer Research and Treatment, 2009
- A novel PRKAR1A mutation associated with hepatocellular carcinoma in a young patient and a variable Carney complex phenotype in affected subjects in older generationsClinical Endocrinology, 2008
- Detection of somatic β‐catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)Clinical Endocrinology, 2008
- Differential Modification of p27 Kip1 Controls Its Cyclin D-cdk4 Inhibitory ActivityMolecular and Cellular Biology, 2008
- Germ-line mutations in p27
Kip1
cause a multiple endocrine neoplasia syndrome in rats and humansProceedings of the National Academy of Sciences, 2006